• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内治疗实验性神经囊虫病用吡喹酮纳米混悬剂-代谢方法。

In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions-a metabolic approach.

机构信息

State University of Goias, Anapolis, Goias, Brazil.

Tropical Pathology and Public Health Institute, Federal University of Goias, Goiania, Goias, Brazil.

出版信息

Drug Deliv Transl Res. 2018 Oct;8(5):1265-1273. doi: 10.1007/s13346-018-0576-7.

DOI:10.1007/s13346-018-0576-7
PMID:30117119
Abstract

Neurocysticercosis is the most common parasitic infection of the nervous system and currently represents a serious public health issue in many regions of Latin America, Asia, and Africa. To date, praziquantel is one of the chosen drugs for the treatment of neurocysticercosis. Its mechanism of action is based on the inhibition of different biochemical pathways within the parasite which contribute to its death. Thus, the aim of this work was to analyze, for the first time, whether the nanoformulations of praziquantel would modify the energetic pathway of Taenia crassiceps cysticerci, after an intracranial inoculation in BALB/c mice. Praziquantel nanosuspensions were formulated with polyvinyl alcohol, poloxamer 188, and poloxamer 407, as stabilizers. These formulations exhibited particle size in a range of 74-285 nm and zeta potential values in a range of - 8.1/- 13.2 depending on the type of stabilizer. Physical stability study at both 4 ± 2 and 25 ± 2 °C indicated that praziquantel (PZQ) nanoparticles were stable in terms of solubility and particle size after 120-day storage. In vivo studies demonstrated that those nanosystems were able to produce significant modifications on the concentrations of oxaloacetate, citrate, pyruvate, alpha-ketoglutarate, malate, succinate, lactate, beta-hydroxybutyrate, fumarate, and propionate involved in the metabolism of Taenia crassiceps cysticerci. Therefore, these nanoformulations may be considered as a promising tool to deliver praziquantel to the brain for the effective management of neurocysticercosis.

摘要

脑囊尾蚴病是最常见的神经系统寄生性感染,目前在拉丁美洲、亚洲和非洲的许多地区都是严重的公共卫生问题。到目前为止,吡喹酮是治疗脑囊尾蚴病的首选药物之一。其作用机制基于抑制寄生虫内的不同生化途径,这些途径有助于寄生虫的死亡。因此,本工作的目的是首次分析吡喹酮的纳米制剂是否会在 BALB/c 小鼠颅内接种后改变猪带绦虫囊尾蚴的能量途径。吡喹酮纳米混悬剂用聚乙烯醇、泊洛沙姆 188 和泊洛沙姆 407 作为稳定剂进行了配方设计。这些制剂的粒径在 74-285nm 范围内,zeta 电位值在-8.1/-13.2 范围内,具体取决于稳定剂的类型。在 4±2℃和 25±2℃下的物理稳定性研究表明,吡喹酮(PZQ)纳米颗粒在 120 天储存后在溶解度和粒径方面是稳定的。体内研究表明,这些纳米系统能够对参与猪带绦虫囊尾蚴代谢的草酰乙酸、柠檬酸、丙酮酸、α-酮戊二酸、苹果酸、琥珀酸、乳酸、β-羟丁酸、富马酸和丙酸盐的浓度产生显著的改变。因此,这些纳米制剂可以被认为是将吡喹酮递送到大脑以有效治疗脑囊尾蚴病的有前途的工具。

相似文献

1
In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions-a metabolic approach.体内治疗实验性神经囊虫病用吡喹酮纳米混悬剂-代谢方法。
Drug Deliv Transl Res. 2018 Oct;8(5):1265-1273. doi: 10.1007/s13346-018-0576-7.
2
Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci.阐明吡喹酮纳米混悬剂对肥胖带绦虫囊尾蚴体内代谢的影响。
Acta Trop. 2016 Sep;161:100-5. doi: 10.1016/j.actatropica.2016.06.002. Epub 2016 Jun 4.
3
Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.口服硝唑尼特治疗实验性神经囊尾蚴病可诱导肥胖带绦虫囊尾蚴的糖异生。
Acta Trop. 2019 Feb;190:361-364. doi: 10.1016/j.actatropica.2018.12.017. Epub 2018 Dec 13.
4
Partial inhibition of the main energetic pathways and its metabolic consequences after treatment with benzimidazole derivatives in experimental neurocysticercosis.苯并咪唑衍生物治疗实验性神经囊尾蚴病后主要能量途径的部分抑制及其代谢后果。
Parasitology. 2019 Oct;146(12):1578-1582. doi: 10.1017/S0031182019000933. Epub 2019 Jul 31.
5
Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.吡喹酮-甲苯咪唑联合用药的杀囊活性:体外与体内研究。
Acta Trop. 2020 Feb;202:105238. doi: 10.1016/j.actatropica.2019.105238. Epub 2019 Oct 25.
6
Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.鼠囊尾蚴病模型:感染时间和治疗时间对阿苯达唑和吡喹酮杀囊效果的影响。
Exp Parasitol. 2015 Feb;149:1-6. doi: 10.1016/j.exppara.2014.12.002. Epub 2014 Dec 8.
7
Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs.在体内用驱虫药物治疗后,猪带绦虫实验性神经囊尾蚴病的 TCA 循环部分逆转增强。
Parasitol Res. 2014 Apr;113(4):1313-7. doi: 10.1007/s00436-014-3770-7. Epub 2014 Jan 31.
8
Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.猪囊尾蚴:宿主治疗改变囊尾蚴中的糖酵解和三羧酸循环。
Exp Parasitol. 2012 Feb;130(2):146-51. doi: 10.1016/j.exppara.2011.11.001. Epub 2011 Nov 22.
9
Taenia crassiceps: energetic and respiratory metabolism from cysticerci exposed to praziquantel and albendazole in vitro.肥胖带绦虫:体外暴露于吡喹酮和阿苯达唑的囊尾蚴的能量和呼吸代谢
Exp Parasitol. 2008 Nov;120(3):221-6. doi: 10.1016/j.exppara.2008.07.008. Epub 2008 Jul 25.
10
Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.抗蠕虫药物的药代动力学变异性:对神经囊虫病治疗的影响。
Expert Rev Clin Pharmacol. 2012 Jan;5(1):21-30. doi: 10.1586/ecp.11.72.

引用本文的文献

1
Nanomaterials as a Potential Target for Infectious Parasitic Agents.纳米材料作为传染性寄生虫潜在的靶标。
Curr Drug Deliv. 2024;21(6):828-851. doi: 10.2174/1567201820666230223085403.
2
The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models.不同剂型吡喹酮在减少小鼠血吸虫病感染前期体内虫体的效果。
Front Public Health. 2022 May 27;10:848633. doi: 10.3389/fpubh.2022.848633. eCollection 2022.
3
Enhanced Intramuscular Bioavailability of Cannabidiol Using Nanocrystals: Formulation, In Vitro Appraisal, and Pharmacokinetics.

本文引用的文献

1
Solid dissolution in a fluid solvent is characterized by the interplay of surface area-dependent diffusion and physical fragmentation.固体在流体溶剂中的溶解过程的特点是表面积相关的扩散和物理碎裂的相互作用。
Sci Rep. 2018 May 16;8(1):7711. doi: 10.1038/s41598-018-25821-x.
2
Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.固体分散体提高吡喹酮的溶出度和口服生物利用度。
Drug Deliv Transl Res. 2018 Jun;8(3):580-590. doi: 10.1007/s13346-018-0487-7.
3
Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
利用纳米晶体增强大麻二酚的肌内生物利用度:制剂、体外评价和药代动力学。
AAPS PharmSciTech. 2022 Mar 14;23(3):85. doi: 10.1208/s12249-022-02239-3.
4
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations.壳聚糖基纳米递药系统在新型三氯苯达唑制剂开发中的应用。
PLoS One. 2018 Dec 12;13(12):e0207625. doi: 10.1371/journal.pone.0207625. eCollection 2018.
阐明低剂量纳米制剂苯硝唑在急性实验性恰加斯病中的作用。
PLoS Negl Trop Dis. 2017 Dec 21;11(12):e0006119. doi: 10.1371/journal.pntd.0006119. eCollection 2017 Dec.
4
Epidemiology of neurocysticercosis and epilepsy, is everything described?神经囊尾蚴病与癫痫的流行病学,已尽述所有方面了吗?
Epilepsy Behav. 2017 Nov;76:146-150. doi: 10.1016/j.yebeh.2017.01.030. Epub 2017 May 16.
5
Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group.人体囊尾蚴病和猪带绦虫病的筛查、诊断与管理:COHEMI项目研究组的技术建议
Trop Med Int Health. 2017 Jul;22(7):881-894. doi: 10.1111/tmi.12887. Epub 2017 Jun 1.
6
Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.用于口服给药的反式白藜芦醇纳米晶体的制备及体外/体内表征
Drug Deliv Transl Res. 2017 Jun;7(3):395-407. doi: 10.1007/s13346-017-0362-y.
7
Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.奥美沙坦酯纳米晶体的制剂、优化及体内外评价
Drug Deliv Transl Res. 2017 Apr;7(2):292-303. doi: 10.1007/s13346-016-0355-2.
8
Epilepsy in the tropics: Emerging etiologies.热带地区的癫痫:新出现的病因
Seizure. 2017 Jan;44:108-112. doi: 10.1016/j.seizure.2016.11.032. Epub 2016 Dec 6.
9
Design and optimization of thermosensitive nanoemulsion hydrogel for sustained-release of praziquantel.用于吡喹酮缓释的热敏纳米乳水凝胶的设计与优化
Drug Dev Ind Pharm. 2017 Apr;43(4):558-573. doi: 10.1080/03639045.2016.1270960. Epub 2017 Jan 5.
10
A benzimidazole derivative (RCB20) in vitro induces an activation of energetic pathways on Taenia crassiceps (ORF strain) cysticerci.一种苯并咪唑衍生物(RCB20)在体外可诱导粗颈绦虫(ORF株)囊尾蚴的能量代谢途径活化。
Exp Parasitol. 2017 Jan;172:12-17. doi: 10.1016/j.exppara.2016.11.002. Epub 2016 Nov 21.